In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds.
Passante
E
E
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.
Ehrhardt
C
C
Sheridan
H
H
Frankish
N
N
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D015550:Cell Degranulation / Q000187:drug effects*; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D039563:Histamine H1 Antagonists, Non-Sedating / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects*; D007192:Indenes / Q000737:chemistry / Q000494:pharmacology*; D015471:Leukemia, Basophilic, Acute / Q000276:immunology*; D008407:Mast Cells / Q000187:drug effects* / Q000276:immunology; D015394:Molecular Structure; D011794:Quercetin / Q000494:pharmacology; D051381:Rats; D016593:Terfenadine / Q000494:pharmacology; D001619:beta-N-Acetylhexosaminidases / Q000378:metabolism
D000975:Antioxidants; D039563:Histamine H1 Antagonists, Non-Sedating; D007192:Indenes; D016593:Terfenadine; D011794:Quercetin; D001619:beta-N-Acetylhexosaminidases